Report Content
- Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
- Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
- Executive Summary
- Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter's Five Force Analysis
- Dutasteride Market, By Type
5.1 Introduction
5.2 Avodart
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Generic Avodart
5.3.1 Market Overview
5.3.2 Market Size and Forecast
- Dutasteride Market, By End User
6.1 Introduction
6.2 Hospital
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Drug store
6.3.1 Market Overview
6.3.2 Market Size and Forecast
- Dutasteride Market, By Geography
7.1 Introduction
7.2 Europe
7.2.1 Europe Dutasteride, By Type
7.2.2 Europe Dutasteride, By End User
7.3 North America
7.3.1 North America Dutasteride, By Type
7.3.2 North America Dutasteride, By End User
7.4 Asia Pacific
7.4.1 Asia Pacific Dutasteride, By Type
7.4.2 Asia Pacific Dutasteride, By End User
7.5 Rest of The World
7.5.1 Rest of The World Dutasteride, By Type
7.5.2 Rest of The World Dutasteride, By End User
- Dutasteride Market, By Geography
8.1 Introduction
8.2 Europe
8.2.1 Europe Dutasteride, By Group
8.2.2 Europe Dutasteride, By Application
8.2.3 Europe Dutasteride, By Type
8.3 North America
8.3.1 North America Dutasteride, By Group
8.3.2 North America Dutasteride, By Application
8.3.3 North America Dutasteride, By Type
8.4 Asia Pacific
8.4.1 Asia Pacific Dutasteride, By Group
8.4.2 Asia Pacific Dutasteride, By Application
8.4.3 Asia Pacific Dutasteride, By Type
8.5 Rest of The World
8.5.1 Rest of The World Dutasteride, By Group
8.5.2 Rest of The World Dutasteride, By Application
8.5.3 Rest of The World Dutasteride, By Type
- Competitive Insights
9.1 Key Insights
9.2 Company Market Share Analysis
9.3 Strategic Outlook
9.3.1 Mergers & Acquisitions
9.3.2 New Product Development
9.3.3 Portfolio/Production Capacity Expansions
9.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
9.3.5 Others
- Company Profiles
(Overview, Key Financials, Recent Developments, Product and Service Offering)
- GSK
- Bionpharma
- Rising Pharmaceuticals
- Teva
- Mylan
- Zydus
- Amneal Pharma
- Apotex
- Marksans Pharma
- Breckenridge Pharmaceutical